CVRX · CVRx, Inc. · Webcasts, Transcripts & Audio
$1.53
+0.00 (+0.00%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$50.49M
Shares
26.64M
Volume · Oct 2
1.05M
Avg daily vol (3M)
884.44K
CVRx, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for CVRx, Inc. (CVRX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲82.2%
$6.19M
−$9.83M
'22 Q3
22-11-01
▲96.2%
$7.18M
−$10.54M
'22 Q4
23-01-26
▲95.8%
$7.98M
−$11.37M
'23 Q1
23-04-27
▲88.8%
$9.50M
−$11.65M
'23 Q2
23-07-25
▲69.9%
$10.51M
−$9.01M
'23 Q3
23-10-26
▲57.5%
$11.30M
−$9.16M
'23 Q4
24-01-25
▲35%
$10.77M
−$22.19M
'24 Q1
24-04-30
▲24.3%
$11.81M
−$14.03M
'24 Q2
24-07-29
▲27.2%
$13.37M
−$13.10M
'24 Q3
24-10-29
▲35.7%
$15.34M
−$10.65M
'24 Q4
25-01-13
▲14.7%
$12.35M
−$13.77M
'25 Q1
25-04-07
▲15.1%
$13.59M
−$14.74M
'25 Q2
25-08-04
▲9.8%
$14.69M
−$12.87M
'25 Q3
25-11-05
▲4.4%
$16.02M
−$11.93M
'25 Q4
26-02-12
▲19.6%
$14.77M
−$13.12M
'26 Q1
26-05-11
LATEST
▲15.6%
$15.71M
−$14.04M
'26 Q2
26-08-06
Conference
Investor event
2026-08-11
CVRx, Inc. (CVRX) August 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-06
CVRx, Inc. (CVRX) Q2 2026 Earnings Call Transcript
Cautious tone
Salesforce turnover and productivity
Reimbursement progress and payment rates
Medicare Advantage prior authorization headwinds
Revenue
$15.71M
▲ 15.6% YoY Diluted EPS
$-0.53
Gross margin
87.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-10
CVRx, Inc. (CVRX) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-02
CVRx, Inc. (CVRX) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-11
CVRx, Inc. (CVRX) Q1 2026 Earnings Call Transcript
Confident tone
Reimbursement progress with Category 1 CPT codes
Medicare Advantage prior authorization disruption
U.S. revenue growth and sales expansion
Revenue
$14.77M
▲ 19.6% YoY Diluted EPS
$-0.50
Gross margin
87.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-12
CVRx, Inc. (CVRX) Q4 2025 Earnings Call Transcript
Positive tone
Revenue growth and commercial investment
Barostim therapy and market opportunity
Category 1 CPT code transition
Revenue
$16.02M*
▲ 4.4% YoY Gross margin
86.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
CVRx, Inc. (CVRX) Q3 2025 Earnings Call Transcript
Confident tone
2026 operating expense leverage
Revenue and financial performance
Q4 guidance and conservatism
Revenue
$14.69M
▲ 9.8% YoY Diluted EPS
$-0.49
Gross margin
86.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-04
CVRx, Inc. (CVRX) Q2 2025 Earnings Call Transcript
Confident tone
Revenue growth and quarterly results
Adoption barriers and war of attrition
Reimbursement progress
Revenue
$13.59M
▲ 15.1% YoY Diluted EPS
$-0.57
Gross margin
84.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-07
CVRx, Inc. (CVRX) Q1 2025 Earnings Call Transcript
Balanced tone
Targeting sustainable centers and program-focused selling
Physician awareness and conferences
Barostim therapy and market opportunity
Revenue
$12.35M
▲ 14.7% YoY Diluted EPS
$-0.53
Gross margin
83.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-13
CVRx, Inc. (CVRX) Q4 2024 Earnings Call Transcript
Confident tone
U.S. Heart Failure Revenue Growth
Reimbursement and CPT Coding
Patient Access and Prior Authorization
Revenue
$15.34M*
▲ 35.7% YoY Gross margin
83.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-29
CVRx, Inc. (CVRX) Q3 2024 Earnings Call Transcript
Confident tone
Barostim therapy adoption and standard-of-care
Reimbursement wins (DRG and CPT codes)
Revenue growth and commercial execution
Revenue
$13.37M
▲ 27.2% YoY Diluted EPS
$-0.57
Gross margin
83.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-29
CVRx, Inc. (CVRX) Q2 2024 Earnings Call Transcript
Positive tone
U.S. Heart Failure business and Barostim adoption
CMS outpatient reimbursement (OPPS proposed rule)
Patient access, education, and direct-to-consumer outreach
Revenue
$11.81M
▲ 24.3% YoY Diluted EPS
$-0.65
Gross margin
83.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-30
CVRx, Inc. (CVRX) Q1 2024 Earnings Call Transcript
Balanced tone
Barostim market opportunity and penetration
New CEO transition and background
Go-to-market priorities: awareness, evidence, access
Revenue
$10.77M
▲ 35% YoY Diluted EPS
$-1.04
Gross margin
85.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-25
CVRx, Inc. (CVRX) Q4 2023 Earnings Call Transcript
Confident tone
Guidance and Cash Discipline
CEO Succession and Leadership Transition
Revenue Growth and Barostim Adoption
Revenue
$11.30M*
▲ 57.5% YoY Gross margin
84.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-26
CVRx, Inc. (CVRX) Q3 2023 Earnings Call Transcript
Revenue
$10.51M
▲ 69.9% YoY Diluted EPS
$-0.43
Gross margin
83.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-25
CVRx, Inc. (CVRX) Q2 2023 Earnings Call Transcript
Revenue
$9.50M
▲ 88.8% YoY Diluted EPS
$-0.56
Gross margin
84.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-27
CVRx, Inc. (CVRX) Q1 2023 Earnings Call Transcript
Revenue
$7.98M
▲ 95.8% YoY Diluted EPS
$-0.55
Gross margin
83.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-26
CVRx, Inc. (CVRX) Q4 2022 Earnings Call Transcript
Revenue
$7.18M*
▲ 96.2% YoY Gross margin
79.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-01
CVRx, Inc. (CVRX) Q3 2022 Earnings Call Transcript
Revenue
$6.19M
▲ 82.2% YoY Diluted EPS
$-0.48
Gross margin
78.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
CVRx, Inc. (CVRX) Q2 2022 Earnings Call Transcript
Revenue
$5.03M
▲ 61.1% YoY Diluted EPS
$-0.54
Gross margin
76.1%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-25
CVRx, Inc. (CVRX) Q1 2022 Earnings Call Transcript
Revenue
$4.08M
▲ 42.5% YoY Diluted EPS
$-0.49
Gross margin
76.7%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-15
CVRx, Inc. (CVRX) Q4 2021 Earnings Call Transcript
Revenue
$3.66M*
Gross margin
73.1%
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
CVRx, Inc. (CVRX) Q3 2021 Earnings Call Transcript
Revenue
$3.40M
▲ 240.5% YoY Diluted EPS
$-0.30
Gross margin
74.2%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
CVRx, Inc. (CVRX) Q2 2021 Earnings Call Transcript
Revenue
$3.12M
▲ 149.8% YoY Diluted EPS
$-48.48
Gross margin
70.8%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–24 of 24 webcasts